Literature DB >> 8293403

National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients.

R D Hightower1, H N Nguyen, H E Averette, W Hoskins, T Harrison, A Steren.   

Abstract

BACKGROUND: An analysis was conducted by the American College of Surgeons Cancer Commission evaluating the patterns of care of ovarian cancer patients diagnosed in 1983 and 1988. The purpose of this study was to investigate whether there was a difference in the care patterns of elderly ovarian cancer patients and its impact on survival.
METHODS: Data were collected from 25 consecutive patients whose disease was diagnosed initially at 904 participating hospitals with cancer programs in 1983 and 1988. The survival and care of patients greater than or equal to 80 years of age were compared to those less than 80 years of age.
RESULTS: Of the 12,316 patients evaluated, 1,115 were 80 years or older. A significant reduction in survival was noted among patients 80 years and older as compared to their younger counterparts (P = 0.03-0.00001). The 5-year survivals were: stage I, 89% versus 79%; stage II, 58% versus 40%; stage III, 25% versus 11%; and stage IV, 13% versus 3%, respectively, for those less than 80 years old as compared to those greater than or equal to 80 years old. Most elderly ovarian cancer patients were cared for by nononcologists such as general surgeons (31%) and obstetricians/gynecologists (29%). As a group, older patients had fewer total abdominal hysterectomies, bilateral salpingo-oophorectomies, and omentectomies than their younger counterpart (P < 0.00001). As further evidence for a less aggressive surgical approach, the optimal tumor debulking rates of women greater than or equal to 80 years were significantly less than those of younger patients (P < 0.001). There was no significant increase in anesthesia complications between age groups. Generally, older patients are less likely to receive adjuvant chemotherapy than younger patients (42% versus 69%, P < 0.0001).
CONCLUSION: It appears that conservative treatments contributed to the decreased survival of older ovarian cancer patients.

Entities:  

Mesh:

Year:  1994        PMID: 8293403     DOI: 10.1002/1097-0142(19940115)73:2<377::aid-cncr2820730223>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  Drug therapy for gynaecological cancer in older women.

Authors:  R E van Rijswijk; J B Vermorken
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Jan H Beumer; Heather A Lankes; William Tew; Thomas Herzog; Arti Hurria; Robert S Mannel; Tina Rizack; Lisa M Landrum; Peter G Rose; Ritu Salani; William H Bradley; Thomas J Rutherford; Robert V Higgins; Angeles Alvarez Secord; Gini Fleming
Journal:  Gynecol Oncol       Date:  2017-01-13       Impact factor: 5.482

3.  Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography.

Authors:  Daniel Polsky; Katrina A Armstrong; Thomas C Randall; Richard N Ross; Orit Even-Shoshan; Paul R Rosenbaum; Jeffrey H Silber
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

4.  Is ovarian cancer undertreated in older women?

Authors:  D L Marchetti; M M Hreshchyshyn
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

5.  Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.

Authors:  Amina Ahmed; Wei Deng; William Tew; David Bender; Robert S Mannel; Ramey D Littell; Albert S DeNittis; Mitchell Edelson; Mark Morgan; Jay Carlson; Christopher J Darus; Aimee C Fleury; Susan Modesitt; Alexander Olawaiye; Anthony Evans; Gini F Fleming
Journal:  Gynecol Oncol       Date:  2018-05-26       Impact factor: 5.482

6.  Doublet chemotherapy in the elderly patient with ovarian cancer.

Authors:  Min Y Teo; Derek G Power; William P Tew; Stuart M Lichtman
Journal:  Oncologist       Date:  2012-08-22

Review 7.  Chemotherapy for ovarian cancer in the older adult.

Authors:  Christopher B Steer
Journal:  Curr Treat Options Oncol       Date:  2009-04-16

8.  CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer.

Authors:  Elizabeth Won; Arti Hurria; Tao Feng; Supriya Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; William P Tew
Journal:  Int J Gynecol Cancer       Date:  2013-07       Impact factor: 3.437

Review 9.  Ovarian cancer cytoreductive surgery in the elderly.

Authors:  Ginger J Gardner
Journal:  Curr Treat Options Oncol       Date:  2009-08

10.  Considerations regarding the administration of systemic therapy for elderly patients with ovarian cancer.

Authors:  William P Tew
Journal:  Curr Treat Options Oncol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.